Evidence map›Paper›PMID 28667332›Full record

ArticleScientific reports2017

Viperin is an important host restriction factor in control of Zika virus infection.

Kylie H Van der Hoek, Nicholas S Eyre, Byron Shue, Onruedee Khantisitthiporn, Kittirat Glab-Ampi, Jillian M Carr, Matthew J Gartner, Lachlan A Jolly, Paul Q Thomas, Fatwa Adikusuma and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
14.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 112 citations in OpenAlex.

  1. Identification of AMOTL2 as an antiviral factor that enhances the human type I interferon response against Zika virus.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Type I interferon receptor (Frontiers in immunology · 2022
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Kylie H Van der HoekMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Nicholas S EyreMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Byron ShueMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Onruedee KhantisitthipornMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Kittirat Glab-AmpiMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Jillian M CarrMicrobiology and Infectious Diseases, School of Medicine, Flinders University, Bedford Park, SA, 5042, Australia.
Matthew J GartnerMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Lachlan A JollyAdelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, SA, 5005, Australia.
Paul Q ThomasMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Fatwa AdikusumaMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia.
Tanja Jankovic-KarasoulosAdelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, SA, 5005, Australia.
Claire T RobertsAdelaide Medical School and Robinson Research Institute, The University of Adelaide, Adelaide, SA, 5005, Australia.
Karla J HelbigDepartment of Physiology, Anatomy and Microbiology, La Trobe University, Melbourne, Vic, 3086, Australia.
Michael R BeardMolecular and Cellular Biology, Research Centre for Infectious Diseases, The University of Adelaide, Adelaide, SA, 5005, Australia. michael.beard@adelaide.edu.au.ORCID 0000-0002-4106-1016
University of South Australia · AUThe University of Adelaide · AUFlinders University · AULa Trobe University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zika virus (ZIKV) infection has emerged as a global health threat and infection of pregnant women causes intrauterine growth restriction, spontaneous abortion and microcephaly in newborns. Here we show using biologically relevant cells of neural and placental origin that following ZIKV infection, there is attenuation of the cellular innate response characterised by reduced expression of IFN-β and associated interferon stimulated genes (ISGs). One such ISG is viperin that has well documented antiviral activity against a wide range of viruses. Expression of viperin in cultured cells resulted in significant impairment of ZIKV replication, while MEFs derived from CRISPR/Cas9 derived viperin

Indexed as

Host-Pathogen InteractionsAnimalsCell LineCRISPR-Cas SystemsDisease Models, AnimalFemaleGene EditingHumansImmunity, InnateMacrophagesMiceMice, KnockoutMonocytesNeural Stem CellsOxidoreductases Acting on CH-CH Group DonorsPlacentaOxidoreductases Acting on CH-CH Group DonorsProteinsRSAD2 protein, humanViperin Protein

Identifiers

PMID28667332
PMCPMC5493656
OpenAlexW2677591396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.